Calidi Biotherapeutics Statistics
Total Valuation
CLDI has a market cap or net worth of $11.30 million. The enterprise value is $21.87 million.
| Market Cap | 11.30M |
| Enterprise Value | 21.87M |
Important Dates
The next estimated earnings date is Monday, August 19, 2024, before market open.
| Earnings Date | Aug 19, 2024 |
| Ex-Dividend Date | n/a |
Share Statistics
CLDI has 6.42 million shares outstanding. The number of shares has increased by 310.77% in one year.
| Shares Outstanding | 6.42M |
| Shares Change (YoY) | +310.77% |
| Shares Change (QoQ) | +110.53% |
| Owned by Insiders (%) | 47.63% |
| Owned by Institutions (%) | 5.35% |
| Float | 21.75M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | n/a |
| Forward PS | n/a |
| PB Ratio | n/a |
| P/FCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 0.13
| Current Ratio | 0.13 |
| Quick Ratio | n/a |
| Debt / Equity | n/a |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -39.11 |
Financial Efficiency
| Return on Equity (ROE) | n/a |
| Return on Assets (ROA) | -259.60% |
| Return on Capital (ROIC) | n/a |
| Revenue Per Employee | n/a |
| Profits Per Employee | -$731,195 |
| Employee Count | 41 |
| Asset Turnover | n/a |
| Inventory Turnover | n/a |
Taxes
In the past 12 months, CLDI has paid $16,000 in taxes.
| Income Tax | 16,000 |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -98.33% in the last 52 weeks. The beta is 0.42, so CLDI's price volatility has been lower than the market average.
| Beta (5Y) | 0.42 |
| 52-Week Price Change | -98.33% |
| 50-Day Moving Average | 2.08 |
| 200-Day Moving Average | 10.44 |
| Relative Strength Index (RSI) | 46.32 |
| Average Volume (20 Days) | 210,094 |
Short Selling Information
The latest short interest is 55,247, so 0.86% of the outstanding shares have been sold short.
| Short Interest | 55,247 |
| Short Previous Month | 22,839 |
| Short % of Shares Out | 0.86% |
| Short % of Float | 0.25% |
| Short Ratio (days to cover) | 0.31 |
Income Statement
| Revenue | n/a |
| Gross Profit | n/a |
| Operating Income | -30.33M |
| Pretax Income | -29.96M |
| Net Income | -29.98M |
| EBITDA | -27.77M |
| EBIT | -29.22M |
| Earnings Per Share (EPS) | -$6.90 |
Balance Sheet
The company has $1.14 million in cash and $11.71 million in debt, giving a net cash position of -$10.57 million or -$1.65 per share.
| Cash & Cash Equivalents | 1.14M |
| Total Debt | 11.71M |
| Net Cash | -10.57M |
| Net Cash Per Share | -$1.65 |
| Equity (Book Value) | -14.57M |
| Book Value Per Share | -2.27 |
| Working Capital | -13.02M |
Cash Flow
In the last 12 months, operating cash flow was -$27.71 million and capital expenditures -$453,000, giving a free cash flow of -$28.16 million.
| Operating Cash Flow | -27.71M |
| Capital Expenditures | -453,000 |
| Free Cash Flow | -28.16M |
| FCF Per Share | -$7.92 |
Margins
| Gross Margin | n/a |
| Operating Margin | n/a |
| Pretax Margin | n/a |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends & Yields
CLDI does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -310.77% |
| Shareholder Yield | -310.77% |
| Earnings Yield | -265.36% |
| FCF Yield | -249.26% |
Analyst Forecast
The average price target for CLDI is $1.67, which is -5.11% lower than the current price. The consensus rating is "Strong Buy".
| Price Target | $1.67 |
| Price Target Difference | -5.11% |
| Analyst Consensus | Strong Buy |
| Analyst Count | 3 |
| Revenue Growth Forecast (5Y) | n/a |
| EPS Growth Forecast (5Y) | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | 2 |